Modified FLOX as first-line chemotherapy for metastatic colorectal cancer patients in the public health system in Brazil: Effectiveness and cost-utility analysis

by NEBULONI, DANIELA R., MAK, MILENA P., SOUZA, FABIANO HAHN, SARAGIOTTO, DANIEL F., JÚLIO, THIAGO, DE CASTRO, GILBERTO, SABBAGA, JORGE, HOFF, PAULO M.
Published 2013

Regorafenib in Patients with Antiangiogenic‐Naïve and Chemotherapy‐Refractory Advanced Colorectal Cancer: Results from a Phase IIb Trial

by Riechelmann, Rachel P., Leite, Luiz S., Bariani, Giovanni M., Glasberg, Joao, Rivelli, Thomas G., da Fonseca, Leonardo Gomes, Nebuloni, Daniela R., Braghiroli, Maria I., Queiroz, Marcelo A., Isejima, Alice M., Kappeler, Christian, Kikuchi, Luciana, Hoff, Paulo M.
Published in Oncologist (2019)